11 Comments
 
Most Helpful

The Carl Marks merchant bank consists of different groups. Some are more well known than others. The most well-known are focused on distressed/special sits/restructuring work, and I'd rank them from best to worst: 1) $500mm+ distress hedge fund (~10 ppl), 2) turnaround business (40+ ppl), 3) investment banking restructuring group (~10 ppl), and 4) Aerospace & Defense Private Equity Fund ("CM Equity"), and 5) M&A group (max deal sizes ~$500mm, sweet spot being $150-250mm). They also have a family office that does deals globally, and some CRE. They seed new funds, such as Stone Goff Partners. Some big PE funds spun out of Carl Marks in the past, including The Jordan Company. The M&A group isn't very well known, and depending on your other offers or options, I'd avoid, unless you want to do LMM/MM M&A. Outside of restructuring/distressed investing, their groups are less known/active. Good luck.

 

I see on LinkedIn somebody who went to a distress HF (Verition) directly from Carl Marks, a guy who went directly to Brightstar Capital (PE), another who went directly to UBS O'Connor HF, and a kid who went from HL RX to Carl Marks RX to Castlelake... looks like they're all distressed investing roles though. I see a kid at Guggenheim RX IB. Somebody on the other thread said a guy exited to MGG Investment Group and Morgan Stanley IB too, but I don't see them on Linkedin. Looks like a lot exited to other boutique rx shops too, or just changed industries entirely.

 

Natus veritatis et perferendis magnam tempora odio. Architecto sit saepe asperiores magnam architecto quas. Et consequatur distinctio excepturi aut. Quo sed sed inventore fugiat et ut odit. Tempore in qui et saepe. Quisquam accusantium nemo illum eos non. Recusandae officia similique aut. Et explicabo suscipit qui quae.

Ipsa ut laborum provident nobis quas ad. Hic ea quia dolore hic quod. Ut et dolore voluptatum reprehenderit maxime quasi beatae.

Vel ut voluptatem possimus suscipit reprehenderit. Doloribus fugiat consequatur natus ipsam.

Fugiat maxime error eos optio qui sed. Facere ut consequuntur dignissimos distinctio quam. Ut sint corporis tempora officia vero. Iste deleniti et sapiente ducimus dolorum eius. Quibusdam soluta consequatur quidem facere earum.

Career Advancement Opportunities

July 2026 Investment Banking

  • Evercore 01 99.4%
  • Moelis & Company 01 98.9%
  • JPMorgan 01 98.3%
  • Guggenheim Partners 01 97.7%
  • Morgan Stanley 07 97.1%

Overall Employee Satisfaction

July 2026 Investment Banking

  • Moelis & Company No 99.4%
  • Evercore No 98.9%
  • Morgan Stanley 01 98.3%
  • Banco Santander 02 97.7%
  • BMO Capital Markets 12 97.1%

Professional Growth Opportunities

July 2026 Investment Banking

  • Evercore 01 99.4%
  • Moelis & Company 01 98.9%
  • Morgan Stanley 06 98.3%
  • Goldman Sachs 01 97.7%
  • JPMorgan 01 97.1%

Total Avg Compensation

July 2026 Investment Banking

  • Vice President (16) $429
  • Associates (46) $258
  • 3rd+ Year Analyst (8) $210
  • 2nd Year Analyst (22) $179
  • Intern/Summer Associate (14) $159
  • 1st Year Analyst (80) $150
  • Intern/Summer Analyst (73) $101
notes
16 IB Interviews Notes

“... there’s no excuse to not take advantage of the resources out there available to you. Best value for your $ are the...”

Leaderboard

1
redever's picture
redever
99.2
2
kanon's picture
kanon
99.0
3
Secyh62's picture
Secyh62
99.0
4
BankonBanking's picture
BankonBanking
99.0
5
dosk17's picture
dosk17
98.9
6
Betsy Massar's picture
Betsy Massar
98.9
7
CompBanker's picture
CompBanker
98.9
8
GameTheory's picture
GameTheory
98.9
9
DrApeman's picture
DrApeman
98.9
10
Mimbs's picture
Mimbs
98.8
success
From 10 rejections to 1 dream investment banking internship

“... I believe it was the single biggest reason why I ended up with an offer...”